Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.84 - $16.79 $528,596 - $1.13 Million
67,423 Added 668.08%
77,515 $645,000
Q1 2024

May 15, 2024

BUY
$13.2 - $17.76 $133,214 - $179,233
10,092 New
10,092 $179,000
Q2 2022

Aug 15, 2022

SELL
$4.66 - $13.96 $120,409 - $360,712
-25,839 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$11.89 - $24.68 $307,225 - $637,706
25,839 New
25,839 $333,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.